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Small molecule binding to G-hairpin and G-triplex: A 
new insight in anticancer drug design targeting G-rich 
regions†  
Arivazhagan Rajendran,‡a Masayuki Endo,*bc Kumi Hidaka,a Marie-Paule Teulade-
Fichou,d Jean-Louis Mergnye and Hiroshi Sugiyama*abc 
Although a number of G-quadruplex binders and chaperones 
have been reported to date, the molecular mechanism of 
quadruplex-drug interaction has never been investigated. For 
instance, the interaction between the quadruplex binders and 
the in-pathway intermediates such as G-hairpin and G-
triplex is not reported so far. To gain new insights on 
quadruplex–drug interactions, we captured the solution-state 
structures of the complexes between a drug-like small 
molecule and G-hairpin/G-triplex. Our results indicated that 
the investigated ligand initially binds to the intermediates and 
induces stepwise folding into a quadruplex. 
G-quadruplex-forming sequences are attractive therapeutic targets 
because of the high abundance of G-rich DNA regions in the human 
genome. Among the G-rich regions, telomeres have attracted 
particular interest as anticancer therapy targets because this region is 
responsible for the stability of the human chromosome. Telomere is 
a repetitive nucleotide sequence of TTAGGG that has a duplex 
region followed by single-stranded 3-overhang of up to few hundred 
nucleobases at each end of a chromosome.1 It is a noncoding region 
that protects the genetic data, making it possible for cells to divide, 
and it plays a vital role in both aging and cancer. It is composed of a 
nucleoprotein complex called shelterin, which protects the telomere 
ends from the DNA-damage-response machinery.2 G-quadruplex-
based anticancer therapy depends on the development and 
application of drugs that can replace the shelterin complex 
competitively by inducing the quadruplex structure and thereby lead 
to telomere dysfunction, which culminates in cell death.3 Several 
quadruplex binders of natural origin4–6 and synthetic molecules7–10 or 
metal complexes,11 have been recognized. Their selectivity towards 
the quadruplex over B-form DNA was studied under bulk conditions. 
However, to the best of our knowledge, the molecular mechanism of 
quadruplex–drug interaction has never been investigated either 
experimentally or by theoretical methods. Thus, the interaction 
between the quadruplex-binders/chaperones and the quadruplex 
intermediates such as G-hairpin and G-triplex is still unknown at 
molecular level. Indeed, even theoretical discussions on this aspect 
of drug binding to these in-pathway intermediates are notably absent 
from the literature. This is mainly because the involvement of such 
intermediates in the folding process of a quadruplex is still not well 
understood. There have been an increasing number of 
experimental12–20 and theoretical21–25 studies on these intermediates 
in quadruplex folding; however, these studies only assumed their 
involvement. We have recently demonstrated the direct and single-
molecule visualization of the solution-state structures of these 
intermediates (induced by salt20) using DNA origami26–30 and high-
speed atomic force microscopy (HS-AFM).31–36 Here, we present 
new insights into the binding of drug–quadruplex intermediates and 
propose the molecular mechanisms involved in the drug-induced 
quadruplex folding. By using our single-molecule method, we 
present the structures of drug–intermediate complexes with 
nanometer resolution. Other methods failed to provide concrete 
evidence for the presence of these intermediates and could not be 
used even to hypothesize such drug–intermediate interactions. The 
ligand that was used for our studies was the bisquinolinium pyridine 
dicarboxamide bearing a linker terminated by biotin (PDC-biotin, 
Fig. 1a).37 
A DNA origami frame (Fig. 1b)28–29 was used to structurally and 
stoichiometrically control the DNA sequences,38 and the drug–
intermediate binding for tetramolecular antiparallel and (3+1)-type 
structures (in which three G-tracts are present in one strand and one 
G-tract in another strand) were investigated.20 For the formation of 
the tetramolecular G-hairpin, we adopted two unique Watson–Crick 
duplexes each containing six contiguous Gs opposite to a nick in the 
complementary strand (see, Fig. 1c and Fig. S1, ESI†). Thus, only 
two G-repeat strands were used out of the four participating strands, 
which could lead to the formation of G-hairpin structure specifically. 
In the case of the tetramolecular G-triplex, the top duplex contained 
six G-G mismatches in the middle, whereas the bottom duplex 
contained six contiguous Gs opposite to a nick in the complementary 
strand (Fig. 1d). This leaves only three strands with G-repeat 
sequences in the middle, which in turn can produce a G-triplex 
structure specifically. To bring the duplexes closer and to promote 
the formation of the desired intermediates, we incorporated 
structural flexibility into the strands by increasing their length. As a 
result, the lengths of the top and bottom duplexes used were 67 and 
77 bp respectively, whereas the length between the two connecting 
sites in the origami was 64 bp. 
The (3+1)-type G-hairpin was formed by adopting two duplexes, 
each containing a single-stranded overhang with GGGGGGTTN 
(where N = A or T) sequence (Fig. 1e and Fig. S2, ESI†). In the case 
of the (3+1)-type G-triplex, the top duplex contained two repeats of 
GGGGGGTTN sequence, whereas the bottom duplex contained one 
such sequence (Fig. 1f). We also investigated the (3+1)-type 
structures that contained three contiguous Gs, as it is naturally 
abundant (Fig. S3, ESI†). All the duplex DNAs used here contained 
single-stranded regions, each 16 bases in length at both termini, 
which are needed for their attachment inside the origami frame 
through complementary base pairing. Small-molecule-induced 
conformational switching was observed by using HS-AFM by 
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monitoring the topological changes of the incorporated duplexes 
from parallel (no structure) to X-shaped (formation of a notable 
intermediate structure). The presence of the ligand in the 
intermediate structure was confirmed by the localization of 
streptavidin (STV) using STV-biotin (biotin present in the ligand) 
binding as a pixel-enhancing marker in the AFM image. 
Regarding the general experimental procedure, we have prepared 
the DNA origami and attached the duplexes of interest in each case. 
The origami assembly was then purified by passing through a 
Sephacryl S-300 filtration column to remove the excess staples and 
unattached duplexes. PDC-biotin ligand was then added to the 
purified origami assembly, which was then immobilized on a mica 
surface. After gently washing the surface to remove the unbound 
origami assembly, STV was added on the surface and the system 
was incubated for 5 min. Imaging was carried out under PDC-biotin-
free buffer after washing the mica surface to remove excess STV. 
For the detailed experimental procedure, see the ESI†. 
Initially, we investigated the tetramolecular hairpin structure. The 
G-repeat sequences are not able to form the hairpin structure in the 
absence of quadruplex inducers such as PDC-biotin and salts (K+ 
and Mg2+), although a minor but significant amount (27%) of hairpin 
structure was formed even in the presence of 5 mM Mg2+. Thus, a 
majority of the incorporated strands adopted a parallel form inside 
the origami frame (Fig. 1c). Interestingly, addition of PDC-biotin 
induced topological changes of the duplexes from parallel to X-
shape by bringing the duplexes closer at the G-repeat region. 
Furthermore, the yield of the X-shape in this case was doubled when 
compared with that obtained under PDC-biotin-free condition. A 
representative zoom-in AFM image is given in Fig. 1c, and the 
zoom-out image in Fig. S4, ESI†.  The calculated yields in each case 
Fig. 1. (a) Line drawing of the structure of PDC-biotin ligand. (b) Schematic explanation of the DNA origami method for the analysis of ligand-induced 
formation of intermediate structures. The immobilization of STV to the biotin present in the ligand is also shown. Representative zoom-in AFM images of 
the DNA origami frame with incorporated duplexes for the tetramolecular antiparallel (c and d) and (3+1)-type (e and f) structures. Parallel and X-shape of 
the incorporated duplexes indicate the unstructured and characteristic intermediate structures, respectively. The bright spot at the middle of X-shape 
indicates the STV-biotin present in the ligand binding. For comparison, the images recorded in the absence of ligand are taken from our parallel study, 
reference [20]. [M13mp18] = 10 nM; [Staples] = 40 nM; [Tris-HCl] = 20 mM, pH 7.6; [MgCl2] = 5 mM (no ligand) 10 mM (with ligand); [EDTA] = 1 
mM; [KCl] = 0 mM; [PDC-biotin] = 1 M; [STV] = 0.2 M. Image size: 300  225 nm (no ligand) and 125  125 nm (with ligand). 
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a,b,cFor comparison, these data are taken from our parallel studies, references [20], [38] and [39] respectively. Numbers in the parenthesis indicate the yield 
of X-shapes with bound STV. [Tris-HCl] = 20 mM, pH 7.6; [MgCl2] = 5 mM (no ligand) or 10 mM (with ligand); [EDTA] = 1 mM; [KCl] = 0 mM; [PDC-
biotin] = 1 M; [STV] = 0.2 M.     
Table 1. The % yield of X-shapes calculated for the G-repeats containing samples. 
are summarized in Table 1. This topological change indicated that 
the ligand induces the formation of a tetramolecular antiparallel 
hairpin structure. The localization of STV in the center of the X-
shape, as indicated by the bright spot in the AFM image, further 
confirmed that the ligand is present in the G-rich core, and 
consequently provided evidence for the ligand-hairpin binding. 
Among the four participating strands, only two strands contained the 
G-repeats and thus the incorporated strands can only form the 
hairpin structure, ignoring the possibility of other types of structure 
such as G-triplex and G-quadruplex. A similar trend was also 
observed for the tetramolecular antiparallel triplex structure (Fig. 1d 
and Fig. S4, ESI†). In this case, 24% of strands formed X-shape in 
the absence of ligand, and addition of ligand induced the formation 
of X-shape in as many instances as 44%. 
In a similar way, we have tested the (3+1)-type hairpin structures 
(see Fig. 1e and Fig. S5 in the ESI†). For structures with six G-
repeats, about 24% of the duplexes adopted parallel form in the 
absence of PDC-biotin, whereas this amount increased to 43% when 
PDC-biotin was added. Sequences containing three Gs were also 
tested, and the obtained X-shapes in the absence and presence of the 
ligand were 6 and 23%, respectively. These observations indicated 
that the ligand induces the (3+1)-type hairpin structure with a 
reasonable yield. It is worth mentioning here that three contiguous 
Gs avoid the potential caveat that may be possible with the relatively 
long six G-repeats. In the latter case, if a zero nucleotide chain 
reversal loop is feasible, the quadruplex may still be formed with 
two G3 runs from the same strand. However, it is not possible with 
the shorter three contiguous Gs, and thus evidencing the ligand-
induced formation of G-hairpin. 
The (3+1)-type triplexes were then investigated (Fig. 1f and Fig. 
S5, ESI†). As can be seen from Table 1, 29% of structures adopted 
X-shape for sequences with six G-repeats in the absence of PDC-
biotin ligand and this amount was increased to 55% when the 
origami assembly was incubated with the ligand. Similar 
conformational changes were also noticed with sequences containing 
three G-repeats. In this case, 11 and 29% of the structures adopted 
X-shape in the absence and in the presence of ligand, respectively 
(Fig. 1f and Fig. S6, ESI†). In all cases, the localization of STV in 
the center of the X-shape indicated clearly that the ligand is present 
in the G-rich core, and consequently evidenced ligand–intermediate 
binding. For comparison, the yields of G-quadruplex structures in 
each case are listed in Table 1. In two of the three systems, the yields 
of the ligand-induced structures follow the order: hairpin < triplex < 
quadruplex, reflecting the energetics of the structures, with lowest 
energy conformation for the quadruplex and highest energy structure 
for the hairpin. 
The binding of STV-biotin in the ligand was also characterized by 
analyzing the height profile. A representative graph of the height 
analysis of the protein particle inside an origami frame is given in 
Fig. 2. The estimated height of the origami frame and STV are 2.07 
and 5.06 nm, respectively. These values are in good agreement with 
the theoretically expected values of 2 and 5 nm, respectively for the 
origami and STV.39-40 
Sequences with the G to T mutation were also tested in selected 
cases to check whether the formation of X-shape was due to the 
formation of a characteristic structure or whether the strands simply 
make physical contact for a short time. The mutated sequences failed 
to adopt X-shape and exhibited 100% parallel form, which indicated 
that the X-shape formed in case of G-repeat sequences is due to the 
formation of a notable intermediate structure (data not shown). 
Sequences 
G-Hairpin G-Triplex G-Quadruplex 
No ligand[a] With ligand No ligand[a] With ligand No ligand With ligand 
Tetramolecular antiparallel structures 
6 G-repeat 27% 54 (15)% 24% 44 (34)% 18%[b] 69 (21)%[c] 
Counted 
origami 
416 174 153 149 331 329 
(3+1)-type structures 
6 G-repeat 24% 43 (12)% 29% 55 (30)% 26%[a] 64 (33)% 
Counted 
origami 
532 112 346 159 406 137 
3 G-repeat 6% 23 (10)% 11% 29 (10)% 16%[a] 40 (16)% 
Counted 
origami 
345 154 432 205 331 138 
Fig. 2. The graph shows a representative height profile estimated from the 
image shown above. The yellow broken line in the image indicates the 
location where the height was measured. 
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Moreover, we have previously reported that STV alone can neither 
bind nor induce the formation of X-shape in G-rich sequences, 
which demonstrates further that formation of X-shape is due to the 
ligand-induced formation of the intermediate structure.39  
In concluding remarks, by using DNA origami as a novel scaffold 
to control the strand polarity, stoichiometry, and number of G-
repeats or G-repeat containing strands, we have investigated the 
formation of G-quadruplex intermediates such as G-hairpin and G-
triplex structures induced by a G-quadruplex-binding PDC-biotin 
ligand. This ligand successfully bound to the G-repeat regions and 
induced the formation of intermediate structures for both 
tetramolecular and (3+1)-type systems. Our studies strongly support 
the assumptions that the G-hairpin and G-triplex are formed as in-
pathway intermediates of G-quadruplex folding (irrespective of 
whether it is induced by salt20 or a ligand). Furthermore, our HS-
AFM investigation could capture the solution-state structures of the 
intermediate–ligand complex with nanometer precision, while no 
parallel report exists in the literature. Moreover, we would like to 
point out that not even a theoretical discussion exists in the literature 
on drug binding to these intermediates. Thus, this communication 
constitutes the first report of research into an unprecedented area of 
intermediate–ligand binding. Based on these results, we could make 
a general hypothesis that the G-quadruplex-binding ligands are not 
merely quadruplex binders, but they would rather initially bind to the 
in-pathway intermediates and induce stepwise folding into a 
quadruplex structure. These mechanistic investigations shed light on 
drug–intermediate binding and could help in the development of 
novel anticancer drugs targeting G-rich regions. Regarding the 
demerits of this study, it is difficult to apply these results directly to 
the human genome inside cells because such conditions are 
completely different. Furthermore, the spatial resolution of the 
analysis of the intermediate–ligand complex should be improved to 
few Angstroms. 
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EXPERIMENTAL SECTION 
Chemicals and reagents. Tris-HCl, EDTA, and MgCl2 were purchased from Nacalai Tesque, Inc. 
(Kyoto, Japan). STV was purchased from Sigma-Aldrich (Japan). PDC-biotin ligand was prepared 
based on the synthetic procedures that we have reported recently (Faverie et al., Biochimie, 2011, 93, 
1357.). Single-stranded M13mp18 DNA was obtained from New England Biolabs, Inc. (Ipswich, MA). 
The staple strands (most of them are 32-mer) for the fabrication of the DNA origami frame, and the 
oligomers for the formation of intermediate structures were received from Sigma Genosys (Hokkaido, 
Japan). The gel-filtration column and sephacryl S-300 were purchased from Bio-Rad Laboratories, Inc. 
(Hercules, CA) and GE Healthcare UK Ltd. (Buckinghamshire, UK), respectively. Water was deionized 
(≥18.0 MΩ cm specific resistance at 25 °C) by a Milli-Q system (Millipore Corp., Bedford, MA). 
 
Preparation of the origami frame and incorporation of the duplexes. Origami frame was prepared 
by annealing the solution of M13mp18 DNA (final concentration of 0.01 µM), staple DNAs (0.04 µM), 
Tris-HCl (20 mM, pH 7.6), EDTA (1 mM) and MgCl2 (5 or 10 mM) from 85 to 15 °C at a rate of -
1.0 °C/min. The duplex DNAs (final concentration of 0.1 µM each) were also prepared using the same 
condition with that of the origami frame. 10-fold excess of each duplex was then mixed with the origami 
frame. Self-assembly of these duplexes inside the origami frame was carried out by re-annealing the 
solution from 50 to 15 °C at a rate of -1.0 °C/min. The duplexes incorporated origami was purified using 
sephacryl S-300 gel-filtration column before HS-AFM imaging. For the experiments in the presence of 
PDC-biotin, the ligand (1 µM of final concentration) was added to the origami solution before 
immobilization on the mica surface. For the design of origami frame and the sequence of staple strands, 
see our previous publication (Endo et al., J. Am. Chem. Soc., 2010, 132, 1592.). 
 
AFM imaging. AFM images were recorded using a fast-scanning AFM system (Nano Live Vision, 
RIBM Co. Ltd., Tsukuba, Japan) with a silicon nitride cantilever (resonant frequency 1.0-2.0 MHz, 
spring constant 0.1-0.3 N/m, EBD tip radius <15 nm, Olympus BL-AC10EGS-A2). 2 µL of sample was 
adsorbed onto a freshly cleaved mica plate (φ 1.5 mm, RIBM Co. Ltd., Tsukuba, Japan) for 5 min at 
room temperature and then the surface was gently washed 3-5 times using 20 mM Tris-HCl buffer 
solution with the same concentration of salt in which origami was prepared. For the experiments in the 
presence of streptavidin (STV), STV (0.2 µM) was added on the mica surface and incubated for 5 min. 
Images were recorded after gently washing the surface. Scanning was performed using the tapping mode. 
All images reported here were recorded with an image acquisition speed of 0.2 frame/s. The yield 
calculations of the parallel and X-shapes were carried out by counting the shapes in the AFM images. 
Note, the term “parallel-shape” doesn’t mean the strand polarity such as parallel G-quadruplex, it rather 










Fig. S1. The DNA sequences used for the preparation of tetramolecular antiparallel G-hairpin, G-triplex and 
G-quadruplexes. The colored regions at the middle are the G-repeat sequences that form the notable structure. 
The bold letter regions at both the termini indicate the single-stranded regions that are needed to attach these 
duplexes inside the origami frame. This figure is taken from the supporting information of our recent report 











5’-CTGTAGCT CATCATGT GGAGACTCTAGAGTGTTCCTGATGGCCGTAGGGGGGTCAAGGCGGTGGGTGCGCGTTGCTCCTCACT GAACACCC TGAACAAA-3’
3’-CCTCTGAGATCTCACAAGGACTACCGGCATGGGGGGAGTTCCGCCACCCACGCGCAACGAGGAGTGA-5’
Bottom duplex:
5’-CGACAATA AACAACAT GAGGAAGTGAGGAGCAACGCGCACCCACCGCCTTAGGGGGGTCACGGCCATCAGGAACACTCTAGAGTCTCCGCTCG AGCAAACA AGAGAATC-3’
3’-CTCCTTCACTCCTCGTTGCGCGTGGGTGGCGGAATGGGGGGAGTGCCGGTAGTCCTTGTGAGATCTCAGAGGCGAGC-5’
3) Tetramolecular G-quadruplex: Six contiguous Gs
Top duplex:
5’-CTGTAGCT CATCATGT GGAGACTCTAGAGTGTTCCTGATGGCCGTAGGGGGGTCAAGGCGGTGGGTGCGCGTTGCTCCTCACT GAACACCC TGAACAAA-3’
3’-CCTCTGAGATCTCACAAGGACTACCGGCAT                   AGTTCCGCCACCCACGCGCAACGAGGAGTGA-5’
1) Tetramolecular G-hairpin: Six contiguous Gs
Bottom duplex:
5’- GAGGAAGTGAGGAGCAACGCGCACCCACCGCCTTA                  TCACGGCCATCAGGAACACTCTAGAGTCTCCGCTCG-3’
3’-CTAAGAGA ACAAACGA CTCCTTCACTCCTCGTTGCGCGTGGGTGGCGGAAT GGGGGG AGTGCCGGTAGTCCTTGTGAGATCTCAGAGGCGAGC TACAACAA ATAACAGC-5’
Top duplex:
5’-CTGTAGCT CATCATGT GGAGACTCTAGAGTGTTCCTGATGGCCGTAGGGGGGTCAAGGCGGTGGGTGCGCGTTGCTCCTCACT GAACACCC TGAACAAA-3’
3’-CCTCTGAGATCTCACAAGGACTACCGGCATGGGGGGAGTTCCGCCACCCACGCGCAACGAGGAGTGA-5’
2) Tetramolecular G-triplex: Six contiguous Gs
Bottom duplex:
5’- GAGGAAGTGAGGAGCAACGCGCACCCACCGCCTTA                  TCACGGCCATCAGGAACACTCTAGAGTCTCCGCTCG-3’






Fig. S2. The DNA sequences used for the preparation of (3+1)-type G-hairpin, G-triplex and G-quadruplexes. 
Six contiguous Gs were used in this case. The colored regions at the middle are the G-repeat sequences that 
form the notable structure. The bold letter regions at both the termini indicate the single-stranded regions that 
are needed to attach these duplexes inside the origami frame. This figure is taken from the supporting 
information of our recent report [Rajendran et al., Angew. Chem. Int. Ed., 2014, 53, 4107.] as we have used 










3’-CTCCTTCACTCCTCGTTGCGCGTGGGTGGCGGAACTT   AAGTGCCGGTAGTCCTTGTGAGATCTCAGAGGCGAGC-5’
5’- CGACAATA AACAACAT GAGGAAGTGAGGAGCAACGCGCACCCACCGCCTTGAATTCACGGCCATCAGGAACACTCTAGAGTCTCCGCTCG AGCAAACA AGAGAATC -3’
2) (3+1)-type G-triplex: Six contiguous Gs
Top duplex:




3’-CTCCTTCACTCCTCGTTGCGCGTGGGTGGCGGAACTT   AAGTGCCGGTAGTCCTTGTGAGATCTCAGAGGCGAGC-5’
5’- CGACAATA AACAACAT GAGGAAGTGAGGAGCAACGCGCACCCACCGCCTTGAATTCACGGCCATCAGGAACACTCTAGAGTCTCCGCTCG AGCAAACA AGAGAATC -3’
1) (3+1)-type G-hairpin: Six contiguous Gs
Top duplex:




3’-CTCCTTCACTCCTCGTTGCGCGTGGGTGGCGGAACTT   AAGTGCCGGTAGTCCTTGTGAGATCTCAGAGGCGAGC-5’
5’- CGACAATA AACAACAT GAGGAAGTGAGGAGCAACGCGCACCCACCGCCTTGAATTCACGGCCATCAGGAACACTCTAGAGTCTCCGCTCG AGCAAACA AGAGAATC -3’






Fig. S3. The DNA sequences used for the preparation of (3+1)-type G-hairpin, G-triplex and G-quadruplexes. 
Three contiguous Gs were used here. The colored regions at the middle are the G-repeat sequences that form 
the notable structure. The bold letter regions at both the termini indicate the single-stranded regions that are 
needed to attach these duplexes inside the origami frame. This figure is taken from the supporting 
information of our recent report [Rajendran et al., Angew. Chem. Int. Ed., 2014, 53, 4107.] as we have used 










3’-CTCCTTCACTCCTCGTTGCGCGTGGGTGGCGGAACTT   AAGTGCCGGTAGTCCTTGTGAGATCTCAGAGGCGAGC-5’
5’- CGACAATA AACAACAT GAGGAAGTGAGGAGCAACGCGCACCCACCGCCTTGAATTCACGGCCATCAGGAACACTCTAGAGTCTCCGCTCG AGCAAACA AGAGAATC -3’
2) (3+1)-type G-triplex: Three contiguous Gs
Top duplex:




3’-CTCCTTCACTCCTCGTTGCGCGTGGGTGGCGGAACTT   AAGTGCCGGTAGTCCTTGTGAGATCTCAGAGGCGAGC-5’
5’- CGACAATA AACAACAT GAGGAAGTGAGGAGCAACGCGCACCCACCGCCTTGAATTCACGGCCATCAGGAACACTCTAGAGTCTCCGCTCG AGCAAACA AGAGAATC -3’
1) (3+1)-type G-hairpin: Three contiguous Gs
Top duplex:




3’-CTCCTTCACTCCTCGTTGCGCGTGGGTGGCGGAACTT   AAGTGCCGGTAGTCCTTGTGAGATCTCAGAGGCGAGC-5’
5’- CGACAATA AACAACAT GAGGAAGTGAGGAGCAACGCGCACCCACCGCCTTGAATTCACGGCCATCAGGAACACTCTAGAGTCTCCGCTCG AGCAAACA AGAGAATC -3’























Fig. S4. Representative zoom-out images of the PDC-biotin ligand-induced formation of tetramolecular 
antiparallel G-hairpin (top) and G-triplex (bottom) structures inside a DNA origami frame. Six contiguous 
Gs were used in this case. Arrows indicate the X-shaped DNA strands with bound STV inside the origami. 
Image size: 800 × 600 nm. [Tris-HCl] = 20 mM, pH 7.6; [MgCl2] = 10 mM; [KCl] = 0 mM; [PDC-biotin] = 






























Fig. S5. Representative zoom-out images of the PDC-biotin ligand-induced formation of (3+1)-type G-
hairpin (top) and G-triplex (bottom) structures formed inside a DNA origami frame. Six contiguous Gs were 
used in this case. Arrows indicate the X-shaped DNA strands with bound STV inside the origami. Image 
size: 800 × 600 nm. [Tris-HCl] = 20 mM, pH 7.6; [MgCl2] = 10 mM; [KCl] = 0 mM; [PDC-biotin] = 1 µM; 






























Fig. S6. Representative zoom-out images of the PDC-biotin ligand-induced formation of (3+1)-type G-
hairpin (top) and G-triplex (bottom) structures formed inside a DNA origami frame. Three contiguous Gs 
were used in this case. Arrows indicate the X-shaped DNA strands with bound STV inside the origami. 
Image size: 800 × 600 nm. [Tris-HCl] = 20 mM, pH 7.6; [MgCl2] = 10 mM; [KCl] = 0 mM; [PDC-biotin] = 
1 µM; [STV] = 0.2 µM. 
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